Chronic Lymphocytic Leukemia (CLL)
Clinical trials play a vital role in moving treatment and research advances forward. The Clinical Trials 201 program tackles common misconceptions and provides clear, actionable information about trials, sharing tools and resources for patients with CLL. Clinical Trials 201 includes:
Understanding Clinical Trial Terminology
Accessing Clinical Trials
This program is supported by Pharmacyclics, an AbbVie Company, and through generous donations from people like you.